Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Arcutis today announced that Amit Munshi has been appointed to its BOD, and announced the retirement of founder and Board member Bhaskar Chaudhuri, PhD.
Read More -
Pasadena, CA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Holidays at the Station is an annual event hosted by Union Station Homeless Services (USHS) to spread holiday cheer with program participants and...
Read More
-
PARAMOUNT GOLD NEVADA RECEIVES DRAFT CONSOLIDATED PERMIT PACKAGE FROM THE STATE OF OREGON FOR THE GRASSY MOUNTAIN GOLD PROJECT
-
8 décembre 2025 RAPPORT SEMESTRIEL AU 30 SEPTEMBRE 2025 Le rapport financier semestriel au 30 septembre 2025 du Groupe S.T. Dupont est désormais en ligne sur le site internet de S.T. Dupont...
-
CHICAGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its first quarter of fiscal year...
-
Revenues Grow 50% YoY to $47.3 Million, Driven by Double-Digit Organic Sales Momentum and Integration of Crown 1 Asset Acquisition EAST RUTHERFORD, NJ, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Mama’s...
-
– 98% reduction in HSV-2 shedding rate, >99% reduction in high viral load shedding rate and 91% reduction in virologically confirmed genital lesion rate observed in 50 mg weekly oral dose of...
-
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare...
-
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of...
-
NORWALK, Conn., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Reed’s, Inc. (NYSE American: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages,...
-
Autolus presented preliminary data from the Phase 1 CARLYSLE trial in patients with severe refractory systemic lupus erythematosus (srSLE) at ASH 2025.
-
WALTHAM, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically...